Cisplatin-fotemustine combination in inoperable non-small cell lung cancer: Preliminary report of a French multicentre phase II trial
Data up to Jan 2025
Total Citations Per Year
Abstract
References (9)
The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent
1961 • 685 citations
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
1986 • 337 citations
Final report of the french multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases
1990 • 243 citations
The expanding role of cisplatin in the treatment of non-small-cell lung cancer.
1989 • 106 citations
European experience with ifosfamide in non-small cell lung cancer.
1989 • 85 citations
Chemotherapy by fotemustine in cerebral metastases of disseminated malignant melanoma
1990 • 82 citations
Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.
1985 • 81 citations
Phase II multicentre study of the nitrosourea fotemustine in inoperable squamous cell lung carcinoma
1989 • 15 citations
SECOND INTERNATIONAL CONFERENCE ON MELANOMA
1989 • 5 citations
Cited By (0)
No citing papers found in database